Login to Your Account

Astrazeneca settles SEC charges over pay to foreign doctors

By Mari Serebrov
Regulatory Editor

Wednesday, August 31, 2016

What's been deemed improper payments to doctors and local officials in China and Russia will cost Astrazeneca plc (AZ) more than $5.5 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription